An important challenge in comparative effectiveness research is the lack of infrastructure to support pragmatic clinical trials, which compare interventions in usual practice settings and subjects. These trials present challenges that differ from those of classical efficacy trials, which are conducted under ideal circumstances, in patients selected for their suitability, and with highly controlled protocols
Currently, there is wide-spread recognition that much of health care is insufficientlygrounded in ev...
Background: The National Institutes of Health (NIH) Health Care Systems Research Collaboratory (NIH ...
The National Institute of Health (NIH) has made significant investments to establish and maintain st...
An important challenge in comparative effectiveness research is the lack of infrastructure to suppor...
Background: The clinical research enterprise is not producing the evidence decision makers arguably ...
Pragmatic clinical trials (PCTs) seek to improve the generalizability and increase the statistical p...
While advances in medical science have led to con-tinued improvements in medical care and health out...
The principles and methods of CER and PCOR have developed primarily with therapeutics in mind, but t...
The $1.1 billion investment in comparative effectiveness research will reshape the evidence-base sup...
Policy makers have clearly indicated--through heavy investment in the Patient Centered Outcomes Rese...
This second article in the series on pragmatic trials describes the challenges in selection of sites...
The $1.1 billion investment in comparative effectiveness research will reshape the evidence-base sup...
The current health-care environment is demanding evidence-based medicine that relies on clinical tri...
Background: Healthcare expenditures in the United States exceed the healthcare expenditures of other...
becauseresearchtosupportclinicaldecisionmakingwith high-qualityevidenceis lackingorbecauseevidence-b...
Currently, there is wide-spread recognition that much of health care is insufficientlygrounded in ev...
Background: The National Institutes of Health (NIH) Health Care Systems Research Collaboratory (NIH ...
The National Institute of Health (NIH) has made significant investments to establish and maintain st...
An important challenge in comparative effectiveness research is the lack of infrastructure to suppor...
Background: The clinical research enterprise is not producing the evidence decision makers arguably ...
Pragmatic clinical trials (PCTs) seek to improve the generalizability and increase the statistical p...
While advances in medical science have led to con-tinued improvements in medical care and health out...
The principles and methods of CER and PCOR have developed primarily with therapeutics in mind, but t...
The $1.1 billion investment in comparative effectiveness research will reshape the evidence-base sup...
Policy makers have clearly indicated--through heavy investment in the Patient Centered Outcomes Rese...
This second article in the series on pragmatic trials describes the challenges in selection of sites...
The $1.1 billion investment in comparative effectiveness research will reshape the evidence-base sup...
The current health-care environment is demanding evidence-based medicine that relies on clinical tri...
Background: Healthcare expenditures in the United States exceed the healthcare expenditures of other...
becauseresearchtosupportclinicaldecisionmakingwith high-qualityevidenceis lackingorbecauseevidence-b...
Currently, there is wide-spread recognition that much of health care is insufficientlygrounded in ev...
Background: The National Institutes of Health (NIH) Health Care Systems Research Collaboratory (NIH ...
The National Institute of Health (NIH) has made significant investments to establish and maintain st...